Next Gen Biotechnology Summit

Oct 18-19, 2019


Dallas, United States of America

                                                                                                         Next Gen Biotech, CEO Investors Summit 2019

The Next Gen Biotech, CEO Investors Summit 2019 is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.

Each year the Next Gen Biotech, CEO Investors Summit 2019 provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.

Our therapeutic workshops feature MDs, CSOs and industry analysts discussing the latest information on pipeline innovation for breakthrough therapeutic topics in biopharma. Seasoned industry executives and analysts delve into timely and relevant business models, deal-making and investment trends on our business roundtables.

Here’s What You Can Expect at Biotechnology Summit 2019:

  • Meet Experts & Influencers Face to Face
  • Networking Opportunities
  • Learning In a New Space
  • New Technologies
  • Have Energy of Like-Minded Individuals
  • Greater Focus

Why Attend?

  • Be in the know about the Industry Challenges and Innovative Solutions for One Health in the USA.
  • Meet Face to Face with Experts and Influencers: Access the Leading International Pharmaceutical, Biotech, Industrial and Biochemical Companies.
  • Identify Trends and Debate about their Impact on this Market.
  • Hear the New Generation of Startups that are Turning Ideas into High Impact Solutions.
  • Explore New Partnering Opportunities and Funding Possibilities.
  • Connect with Key Players in the Life Sciences Sector, such as Large Companies, Hospitals, Laboratories, Universities, Public agencies, Investors, and Entrepreneurs.
  • Research & Developments in the Genetic Engineering with CRISPR/Cas 9 Techniques.

Who Attends?

  • Industry Executives
  • Entrepreneurs & Startups
  • Investors & Financiers
  • Researchers, Universities & Research Centers
  • Accelerators, Incubators and Associations
  • Government Representatives
  • Service Providers (Consultants, IP Firms, Trade Offices, etc.)
  • Among others.

Why Investors Attend

  • Hear from and meet one-on-one with management from the top biotechnology companies.
  • Evaluate fresh investment opportunities including compatible, complementary and competitive companies.
  • Attend candid panel discussions with leading clinical experts and company experts on the latest therapies and technologies in development.
  • Get a ‘big picture’ overview of the industry and the issues affecting investments now and in the future.

Why Companies Attend

  • Present company story to an audience of target investors.
  • Meet one-on-one with new and current investors, analysts, investment bankers and other potential corporate partners.
  • Hear candid panel discussions and keynotes by veteran investment and company executives.
  • Network with peers, investors and potential partners attending the conference.
  • Get the pulse on the current and proposed investment trends in biotechnology.

Details of Biotechnology CEO & Investor Summit 2019:

Conference Name Place Date
Next Gen Biotechnology CEO Investor Summit 2019 Dallas, USA October 18-19, 2019

Program Overview